These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15096820)

  • 1. Beneficial effects of oral uridine in mitochondrial toxicity.
    Walker UA; Langmann P; Miehle N; Zilly M; Klinker H; Petschner F
    AIDS; 2004 Apr; 18(7):1085-6. PubMed ID: 15096820
    [No Abstract]   [Full Text] [Related]  

  • 2. Uridine supplementation enhances hepatic mitochondrial function in thymidine-analogue treated HIV-infected patients.
    Banasch M; Goetze O; Knyhala K; Potthoff A; Schlottmann R; Kwiatek MA; Bulut K; Schmitz F; Schmidt WE; Brockmeyer NH
    AIDS; 2006 Jul; 20(11):1554-6. PubMed ID: 16847412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uridine in the prevention and treatment of NRTI-related mitochondrial toxicity.
    Walker UA; Venhoff N
    Antivir Ther; 2005; 10 Suppl 2():M117-23. PubMed ID: 16152713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stavudine in antiretroviral therapy: is this the end?
    Brinkman K
    AIDS; 2009 Aug; 23(13):1727-9. PubMed ID: 19571724
    [No Abstract]   [Full Text] [Related]  

  • 5. Miller Fisher variant of Guillain-Barré syndrome associated with lactic acidosis and stavudine therapy.
    Shah SS; Rodriguez T; McGowan JP
    Clin Infect Dis; 2003 May; 36(10):e131-3. PubMed ID: 12746793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replacing stavudine by abacavir reduces lactate levels and may improve lipoatrophy.
    García-Benayas T; Blanco F; de la Cruz JJ; Soriano V; González-Lahoz J
    AIDS; 2003 Apr; 17(6):921-4. PubMed ID: 12660543
    [No Abstract]   [Full Text] [Related]  

  • 7. Occurrence of stavudine-induced lactic acidosis in 3 members of an African family.
    Fielder J; Rambiki K
    J Int Assoc Physicians AIDS Care (Chic); 2010; 9(4):236-9. PubMed ID: 20798404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stavudine-induced macrocytosis during therapy for human immunodeficiency virus infection.
    Martin GJ; Blazes DL; Mayers DL; Spooner KM
    Clin Infect Dis; 1999 Aug; 29(2):459-60. PubMed ID: 10476771
    [No Abstract]   [Full Text] [Related]  

  • 9. Puerperal febrile morbidity associated with the reverse transcriptase inhibitor stavudine.
    Wax JR; Mueller S
    J Matern Fetal Med; 1997; 6(2):118-9. PubMed ID: 9086430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lamivudine-stavudine-induced liver failure in hepatitis B cirrhosis.
    Schiano TD; Lissoos TW; Ahmed A; Siano C; Zaitman D; Cohn G; Ehrenpreis ED
    Am J Gastroenterol; 1997 Sep; 92(9):1563-4. PubMed ID: 9317091
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term safety and efficacy of nevirapine, stavudine and lamivudine in a real-world setting.
    Shalit P; Farrell P; Lindgren P
    AIDS; 2001 Apr; 15(6):804-5. PubMed ID: 11371699
    [No Abstract]   [Full Text] [Related]  

  • 12. Symptomatic hyperlactatemia in an HIV-positive patient: a case report and discussion.
    Antoniou T; Weisdorf T; Gough K
    CMAJ; 2003 Jan; 168(2):195-8. PubMed ID: 12538549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete reversibility of severe nucleoside-induced lipodystrophy.
    Strobel M; Muller P; Claudel P
    AIDS; 1999 Dec; 13(18):2606-7. PubMed ID: 10630538
    [No Abstract]   [Full Text] [Related]  

  • 14. Lactic acidosis secondary to nucleoside analogue antiretroviral therapy.
    Khouri S; Cushing H
    AIDS Read; 2000 Oct; 10(10):602-6. PubMed ID: 11068807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactic acidosis associated with stavudine administration: a report of five cases.
    Mokrzycki MH; Harris C; May H; Laut J; Palmisano J
    Clin Infect Dis; 2000 Jan; 30(1):198-200. PubMed ID: 10619755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excess peripheral neuropathy in patients treated with hydroxyurea plus didanosine and stavudine for HIV infection.
    Cepeda JA; Wilks D
    AIDS; 2000 Feb; 14(3):332-3. PubMed ID: 10716516
    [No Abstract]   [Full Text] [Related]  

  • 17. Renal tubular acidosis and hypophosphataemia after treatment with nucleoside reverse transcriptase inhibitors.
    Morris AA; Baudouin SV; Snow MH
    AIDS; 2001 Jan; 15(1):140-1. PubMed ID: 11192863
    [No Abstract]   [Full Text] [Related]  

  • 18. Lipodystrophy and long-term therapy with nucleoside reverse transcriptase inhibitors.
    Moreno S; Martínez E
    AIDS; 2000 May; 14(7):905-6. PubMed ID: 10839605
    [No Abstract]   [Full Text] [Related]  

  • 19. The genetic toxicity effects of lamivudine and stavudine antiretroviral agents.
    Guimarães NN; de Andrade HH; Lehmann M; Dihl RR; Cunha KS
    Expert Opin Drug Saf; 2010 Sep; 9(5):771-81. PubMed ID: 20377473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleoside analogues and mitochondrial toxicity.
    Fleischer R; Boxwell D; Sherman KE
    Clin Infect Dis; 2004 Apr; 38(8):e79-80. PubMed ID: 15095236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.